168 related articles for article (PubMed ID: 26220739)
1. Autoantibodies to asialoglycoprotein receptor (ASGPR) in patients with autoimmune liver diseases.
Villalta D; Mytilinaiou MG; Elsner M; Hentschel C; Cuccato J; Somma V; Schierack P; Roggenbuck D; Bogdanos DP
Clin Chim Acta; 2015 Oct; 450():1-5. PubMed ID: 26220739
[TBL] [Abstract][Full Text] [Related]
2. Autoantibodies to asialoglycoprotein receptor (ASGPR) measured by a novel ELISA--revival of a disease-activity marker in autoimmune hepatitis.
Hausdorf G; Roggenbuck D; Feist E; Büttner T; Jungblut PR; Conrad K; Berg C; Klein R
Clin Chim Acta; 2009 Oct; 408(1-2):19-24. PubMed ID: 19576873
[TBL] [Abstract][Full Text] [Related]
3. Anti-asialoglycoprotein receptor autoantibodies, detected by a capture-immunoassay, are associated with autoimmune liver diseases.
Yoshioka M; Mizuno M; Morisue Y; Shimada M; Hirai M; Nasu J; Okada H; Sakaguchi K; Yamamoto K; Tsuji T
Acta Med Okayama; 2002 Apr; 56(2):99-105. PubMed ID: 12002624
[TBL] [Abstract][Full Text] [Related]
4. Diagnostic accuracy of atypical p-ANCA in autoimmune hepatitis using ROC- and multivariate regression analysis.
Terjung B; Bogsch F; Klein R; Söhne J; Reichel C; Wasmuth JC; Beuers U; Sauerbruch T; Spengler U
Eur J Med Res; 2004 Sep; 9(9):439-48. PubMed ID: 15546809
[TBL] [Abstract][Full Text] [Related]
5. [Autoimmune hepatitis and overlap syndrome: diagnosis].
Berg PA; Klein R
Praxis (Bern 1994); 2002 Aug; 91(34):1339-46. PubMed ID: 12233264
[TBL] [Abstract][Full Text] [Related]
6. Autoantibodies to asialoglycoprotein receptor in chronic hepatitis C patients.
Husa P; Chalupa P; Stroblová H; Husová L; Slesinger P; Zajíc J
Acta Virol; 2001 Feb; 45(1):7-11. PubMed ID: 11394582
[TBL] [Abstract][Full Text] [Related]
7. Antineutrophil nuclear antibodies (ANNA) in primary biliary cirrhosis: their prevalence and antigen specificity.
Orth T; Gerken G; Meyer Zum Büschenfelde KH; Mayet WJ
Z Gastroenterol; 1997 Feb; 35(2):113-21. PubMed ID: 9066101
[TBL] [Abstract][Full Text] [Related]
8. IgA anti-b2GPI antibodies in patients with autoimmune liver diseases.
Gabeta S; Norman GL; Gatselis N; Liaskos C; Papamichalis PA; Garagounis A; Zachou K; Rigopoulou EI; Dalekos GN
J Clin Immunol; 2008 Sep; 28(5):501-11. PubMed ID: 18551357
[TBL] [Abstract][Full Text] [Related]
9. [Autoimmune liver diseases and their overlap syndromes].
Strassburg CP
Praxis (Bern 1994); 2006 Sep; 95(36):1363-81. PubMed ID: 16989180
[TBL] [Abstract][Full Text] [Related]
10. Autoimmune diseases of the liver and biliary tract and overlap syndromes in childhood.
Maggiore G; Riva S; Sciveres M
Minerva Gastroenterol Dietol; 2009 Mar; 55(1):53-70. PubMed ID: 19212308
[TBL] [Abstract][Full Text] [Related]
11. Organ and non-organ specific autoantibody titres and IgG levels as markers of disease activity: a longitudinal study in childhood autoimmune liver disease.
Gregorio GV; McFarlane B; Bracken P; Vergani D; Mieli-Vergani G
Autoimmunity; 2002 Dec; 35(8):515-9. PubMed ID: 12765477
[TBL] [Abstract][Full Text] [Related]
12. Autoantibodies to beta tubulin in autoimmune liver diseases-Relation to pANCA and clinical relevance.
Preuß B; Frank A; Terjung B; Spengler U; Berg C; Klein R
Clin Exp Immunol; 2024 Apr; 216(2):146-158. PubMed ID: 37823420
[TBL] [Abstract][Full Text] [Related]
13. Autoantibodies to human asialoglycoprotein receptor in autoimmune-type chronic hepatitis.
Treichel U; Poralla T; Hess G; Manns M; Meyer zum Büschenfelde KH
Hepatology; 1990 Apr; 11(4):606-12. PubMed ID: 1691732
[TBL] [Abstract][Full Text] [Related]
14. Diagnostic accuracy of four different immunological methods for the detection of anti-F-actin autoantibodies in type 1 autoimmune hepatitis and other liver-related disorders.
Villalta D; Bizzaro N; Da Re M; Tozzoli R; Komorowski L; Tonutti E
Autoimmunity; 2008 Feb; 41(1):105-10. PubMed ID: 18176872
[TBL] [Abstract][Full Text] [Related]
15. Autoimmune liver disease 2007.
Muratori P; Granito A; Pappas G; Muratori L; Lenzi M; Bianchi FB
Mol Aspects Med; 2008; 29(1-2):96-102. PubMed ID: 18067956
[TBL] [Abstract][Full Text] [Related]
16. [Presence of SLA/LP autoantibodies in patients with primary biliary cirrhosis as a marker for secondary autoimmune hepatitis (overlap syndrome)].
Kanzler S; Bozkurt S; Herkel J; Galle PR; Dienes HP; Lohse AW
Dtsch Med Wochenschr; 2001 Apr; 126(16):450-6. PubMed ID: 11360449
[TBL] [Abstract][Full Text] [Related]
17. [The significance of anti-soluble liver antigen/liver-pancreas in diagnosing and typing autoimmune hepatitis].
Zhao Y; Yan HP; Tan YF; Feng X; Liu Y; Cui D; Ma DM; Li WH; Zhang HP
Zhonghua Gan Zang Bing Za Zhi; 2007 Apr; 15(4):283-6. PubMed ID: 17456317
[TBL] [Abstract][Full Text] [Related]
18. Autoantibodies in chronic liver disease.
Ghonaim M; Al-Ghamdi A; El-Bana H; Bakr A; Ghoneim E; El-Edel R; Hassona M; Shoeib S; Allam H
Egypt J Immunol; 2005; 12(2):101-11. PubMed ID: 17977215
[TBL] [Abstract][Full Text] [Related]
19. High frequency of autoantibodies in patients with primary sclerosing cholangitis that bind biliary epithelial cells and induce expression of CD44 and production of interleukin 6.
Xu B; Broome U; Ericzon BG; Sumitran-Holgersson S
Gut; 2002 Jul; 51(1):120-7. PubMed ID: 12077104
[TBL] [Abstract][Full Text] [Related]
20. Detection of circulating autoantibodies directed against the asialoglycoprotein receptor using recombinant receptor subunit H1.
Schreiter T; Liu C; Gerken G; Treichel U
J Immunol Methods; 2005 Jun; 301(1-2):1-10. PubMed ID: 15890353
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
